The role of aflibercept in the management of diabetic macular edema
Andrew A Chang,1–3 Thomas Hong,1,2 Shaun Y Ewe,1,2 Bobak Bahrami,1,2 Geoffrey K Broadhead1–3 1Sydney Institute of Vision Science, 2Sydney Retina Clinic and Day Surgery, 3Save Sight Institute, University of Sydney, Sydney, NSW, Australia Abstract: Diabetic macular edema (DME) rep...
Main Authors: | Chang AA, Hong T, Ewe SY, Bahrami B, Broadhead GK |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-08-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/the-role-of-aflibercept-in-the-management-of-diabetic-macular-edema-peer-reviewed-article-DDDT |
Similar Items
-
Aflibercept compared with dexamethasone in diabetic macular edema
by: Rodolfo Garretón, et al.
Published: (2021-05-01) -
The clinical utility of aflibercept for diabetic macular edema
by: Stewart MW
Published: (2015-09-01) -
The efficacy and safety of aflibercept and conbercept in diabetic macular edema
by: Cai S, et al.
Published: (2018-10-01) -
Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
by: Kendra A. Klein, et al.
Published: (2017-04-01) -
Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
by: Lim LS, et al.
Published: (2015-09-01)